Skip to main content
. 2023 May 3;64(Suppl 1):i8–i15. doi: 10.1093/jrr/rrad017

Table 4.

Univariate analyses for OS and PFS

Factors N (%) OS P-value PFS P-value
Primary tumor
T0–2 38 (52%) 0.14 0.66
T3–4 35 (48%)
Regional lymph nodes
N0–1 12 (16%) 0.68 0.28
N2 27 (36%)
N3 35 (47%)
Primary tumor site
Lower lobe 26 (35%) 0.081 0.0051
Other sites 48 (65%)
Pathology
Adenocarcinoma 42 (57%) 0.95 0.69
Squamous cell carcinoma 26 (35%)
Other pathologies 6 (8%)